Microscopic nuclei classification, segmentation, and detection with improved deep convolutional neural networks (DCNN)

Author:

Alom ZahangirORCID,Asari Vijayan K.,Parwani Anil,Taha Tarek M.

Abstract

Abstract Background Nuclei classification, segmentation, and detection from pathological images are challenging tasks due to cellular heterogeneity in the Whole Slide Images (WSI). Methods In this work, we propose advanced DCNN models for nuclei classification, segmentation, and detection tasks. The Densely Connected Neural Network (DCNN) and Densely Connected Recurrent Convolutional Network (DCRN) models are applied for the nuclei classification tasks. The Recurrent Residual U-Net (R2U-Net) and the R2UNet-based regression model named the University of Dayton Net (UD-Net) are applied for nuclei segmentation and detection tasks respectively. The experiments are conducted on publicly available datasets, including Routine Colon Cancer (RCC) classification and detection and the Nuclei Segmentation Challenge 2018 datasets for segmentation tasks. The experimental results were evaluated with a five-fold cross-validation method, and the average testing results are compared against the existing approaches in terms of precision, recall, Dice Coefficient (DC), Mean Squared Error (MSE), F1-score, and overall testing accuracy by calculating pixels and cell-level analysis. Results The results demonstrate around 2.6% and 1.7% higher performance in terms of F1-score for nuclei classification and detection tasks when compared to the recently published DCNN based method. Also, for nuclei segmentation, the R2U-Net shows around 91.90% average testing accuracy in terms of DC, which is around 1.54% higher than the U-Net model. Conclusion The proposed methods demonstrate robustness with better quantitative and qualitative results in three different tasks for analyzing the WSI.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference46 articles.

1. Van Norman GA. Drugs, devices, and the fda: part 1: an overview of approval processes for drugs. JACC: Basic to Transl Sci. 2016;1(3):170–9. https://doi.org/10.1016/j.jacbts.2016.03.002.

2. Rojo MG, Punys V, Slodkowska J, Schrader T, Daniel C, Blobel B. Digital pathology in europe: coordinating patient care and research efforts. Stud Health Technol Inform. 2009;150:997–1001.

3. Rojo MG. State of the art and trends for digital pathology. Stud Health Technol Inform. 2012;179:15–28.

4. Pantanowitz L, Sinard JH, Henricks WH, Fatheree LA, Carter AB, Contis L, et al. Validating whole slide imaging for diagnostic purposes in pathology: guideline from Alom et al. Page 20 of 21 the college of american pathologists pathology and laboratory quality center. Archives of Pathology and Laboratory Medicine. 2013;137(12):1710–22.

5. L’opez C, Lejeune M, Bosch R, Korzynska A, Garc’ıa-Rojo M, Salvad’o M-T, et al. Digital image analysis in breast cancer: an example of an automated methodology and the effects of image compression. Stud Health Technol Inform. 2012;179:155–71.

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3